Microbial Drug Resistance

Yayıncı: Mary Ann Liebert Inc.
Ülke: United States · Northern America
Tür: journal
ISSN: 10766294

19318448

Scopus 0,605 SJR

Scopus Q2 SJR Q

WoS Q3 JCR Q

WoS 1,8 JIF

Scopus 80 H-Index

Bütünleşik değerlendirme

Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.

WoS / JCR verileri 1997 ve sonrası içindir.

Scopus

Scopus · Scimago

SJR 0,605
Quartile Q2
H-Index 80
Atıf/yayın 1,81
Doküman (3y) 267
Atıf (3y) 544

Clarivate

Web of Science · JCR · 2025

JCR Q Q3
JIF 1,8
5Y JIF 2,1
JCI 0,51

WoS indeksleri

SCIE

Konu sınıflandırması

Kategoriler (SJR)

Immunology Q3
Medicine (miscellaneous) Q2
Microbiology Q3
Microbiology (medical) Q3
Pharmacology Q3

Alanlar

Immunology and Microbiology
Medicine
Pharmacology, Toxicology and Pharmaceutics

WoS kategorileri

Infectious Diseases | Microbiology | Pharmacology & Pharmacy

Yıllık quartile karşılaştırması

Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.

WoS / JCR verileri 1997 ve sonrası içindir.

Not: JCR Q, JIF, 5Y JIF, JCI ve JCI Q sütunları 1997 öncesi için boştur — bu sitede WoS/JCR verisi 1997’den başlar.
Yıl	SJR Q	JCR Q (1997+)	SJR	JIF (1997+)	5Y JIF (1997+)	JCI (1997+)	JCI Q (1997+)	H-Index
2025	Q2	Q3	0,605	1,8	2,1	0,51	Q3	80
2024	Q2	Q3	0,627	1,9	2,3	0,56	Q3	79
2023	Q2	Q3	0,596	2,3	3,5	0,56	Q3	79
2022	Q2	Q3	0,589	2,6	2,9	0,62	Q2	79
2021	Q2	Q3	0,648	2,7	2,9	0,67	Q2	79
2020	Q2	Q3	0,889	3,4	3,3	0,92	Q2	79
2019	Q1	Q3	0,881	2,5	2,4	0,9	Q2	79
2018	—	Q3	—	2,4	2,4	0,83	Q2	—
2017	Q1	Q3	0,957	2,3	2,4	0,79	Q2	79
2016	Q1	Q3	1,015	2,3	2,3	—	—	79
2015	Q1	Q2	1,04	2,5	2,3	—	—	79
2014	Q1	Q2	0,959	2,5	2,2	—	—	79
2013	Q1	Q2	1,265	2,5	2,5	—	—	79
2012	Q1	Q2	0,963	2,4	2,1	—	—	79
2011	Q1	Q2	1,163	2,2	2,3	—	—	79
2010	Q1	Q3	1,054	1,9	1,8	—	—	79
2009	—	Q3	—	2	2	—	—	—
2008	—	Q3	—	1,8	1,8	—	—	—
2007	—	Q3	—	1,5	1,8	—	—	—
2006	—	Q3	—	1,9	—	—	—	—
2005	—	Q2	—	2,1	—	—	—	—
2004	—	Q3	—	1,8	—	—	—	—
2003	—	Q2	—	2,3	—	—	—	—
2002	—	Q1	—	2,6	—	—	—	—
2001	—	Q1	—	2,6	—	—	—	—
2000	—	Q1	—	3,3	—	—	—	—
1999	—	Q1	—	3,4	—	—	—	—
1998	—	Q1	—	2,5	—	—	—	—
1997	—	Q2	—	1,9	—	—	—	—

JCR kategori quartile geçmişi

Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.

WoS / JCR verileri 1997 ve sonrası içindir.

Not: Bu tablo 1997+ Clarivate kategori quartile kayıtlarını gösterir.
Yıl	Kategori	Edition	JCR Q (1997+)	JCI Q (1997+)	Sıra
2025	INFECTIOUS DISEASES	SCIE	Q3	Q3	105/141
2025	MICROBIOLOGY	SCIE	Q4	Q3	143/167
2025	PHARMACOLOGY & PHARMACY	SCIE	Q3	Q3	258/356
2024	INFECTIOUS DISEASES	SCIE	Q3	Q3	93/137
2024	MICROBIOLOGY	SCIE	Q4	Q3	128/163
2024	PHARMACOLOGY & PHARMACY	SCIE	Q3	Q3	238/352
2023	INFECTIOUS DISEASES	SCIE	Q3	Q3	81/132
2023	MICROBIOLOGY	SCIE	Q3	Q3	109/161
2023	PHARMACOLOGY & PHARMACY	SCIE	Q3	Q3	199/354
2022	INFECTIOUS DISEASES	SCIE	Q3	Q2	71/96
2022	MICROBIOLOGY	SCIE	Q3	Q3	99/135
2022	PHARMACOLOGY & PHARMACY	SCIE	Q3	Q3	183/278
2021	INFECTIOUS DISEASES	SCIE	Q4	Q2	73/95
2021	MICROBIOLOGY	SCIE	Q4	Q2	105/137
2021	PHARMACOLOGY & PHARMACY	SCIE	Q3	Q2	193/279
2020	INFECTIOUS DISEASES	SCIE	Q3	Q2	49/93
2020	MICROBIOLOGY	SCIE	Q3	Q2	71/136
2020	PHARMACOLOGY & PHARMACY	SCIE	Q3	Q2	139/276
2019	INFECTIOUS DISEASES	SCIE	Q3	Q2	54/92
2019	MICROBIOLOGY	SCIE	Q3	Q2	82/136
2019	PHARMACOLOGY & PHARMACY	SCIE	Q3	Q2	153/271
2018	INFECTIOUS DISEASES	SCIE	Q3	Q2	52/89
2018	MICROBIOLOGY	SCIE	Q3	Q2	86/133
2018	PHARMACOLOGY & PHARMACY	SCIE	Q3	Q2	149/267
2017	INFECTIOUS DISEASES	SCIE	Q3	Q2	51/88
2017	MICROBIOLOGY	SCIE	Q3	Q2	70/126
2017	PHARMACOLOGY & PHARMACY	SCIE	Q3	Q2	142/261
2016	INFECTIOUS DISEASES	SCIE	Q3	—	53/84
2016	MICROBIOLOGY	SCIE	Q3	—	69/125
2016	PHARMACOLOGY & PHARMACY	SCIE	Q3	—	138/257
2015	INFECTIOUS DISEASES	SCIE	Q2	—	40/83
2015	MICROBIOLOGY	SCIE	Q2	—	61/123
2015	PHARMACOLOGY & PHARMACY	SCIE	Q2	—	110/255
2014	INFECTIOUS DISEASES	SCIE	Q3	—	42/78
2014	MICROBIOLOGY	SCIE	Q3	—	62/119
2014	PHARMACOLOGY & PHARMACY	SCIE	Q2	—	116/255
2013	INFECTIOUS DISEASES	SCIE	Q3	—	39/72
2013	MICROBIOLOGY	SCIE	Q2	—	56/119
2013	PHARMACOLOGY & PHARMACY	SCIE	Q2	—	110/256
2012	INFECTIOUS DISEASES	SCIE	Q3	—	39/70
2012	MICROBIOLOGY	SCIE	Q3	—	59/116
2012	PHARMACOLOGY & PHARMACY	SCIE	Q2	—	117/261
2011	INFECTIOUS DISEASES	SCIE	Q3	—	44/70
2011	MICROBIOLOGY	SCIE	Q3	—	65/114
2011	PHARMACOLOGY & PHARMACY	SCIE	Q2	—	130/261
2010	INFECTIOUS DISEASES	SCIE	Q3	—	43/58
2010	MICROBIOLOGY	SCIE	Q3	—	67/107
2010	PHARMACOLOGY & PHARMACY	SCIE	Q3	—	143/252
2009	INFECTIOUS DISEASES	SCIE	Q3	—	39/57
2009	MICROBIOLOGY	SCIE	Q3	—	60/95
2009	PHARMACOLOGY & PHARMACY	SCIE	Q3	—	140/237
2008	INFECTIOUS DISEASES	SCIE	Q4	—	40/51
2008	MICROBIOLOGY	SCIE	Q3	—	59/91
2008	PHARMACOLOGY & PHARMACY	SCIE	Q3	—	134/219
2007	INFECTIOUS DISEASES	SCIE	Q4	—	42/50
2007	MICROBIOLOGY	SCIE	Q3	—	63/93
2007	PHARMACOLOGY & PHARMACY	SCIE	Q3	—	136/205
2006	INFECTIOUS DISEASES	SCIE	Q3	—	34/47
2006	MICROBIOLOGY	SCIE	Q3	—	61/89
2006	PHARMACOLOGY & PHARMACY	SCIE	Q3	—	101/199
2005	INFECTIOUS DISEASES	SCIE	Q3	—	26/43
2005	MICROBIOLOGY	SCIE	Q3	—	51/86
2005	PHARMACOLOGY & PHARMACY	SCIE	Q2	—	83/193
2004	INFECTIOUS DISEASES	SCIE	Q3	—	25/41
2004	MICROBIOLOGY	SCIE	Q3	—	50/84
2004	PHARMACOLOGY & PHARMACY	SCIE	Q3	—	97/187
2003	INFECTIOUS DISEASES	SCIE	Q2	—	11/41
2003	MICROBIOLOGY	SCIE	Q2	—	28/84
2003	PHARMACOLOGY & PHARMACY	SCIE	Q2	—	57/185
2002	INFECTIOUS DISEASES	SCIE	Q2	—	10/38
2002	MICROBIOLOGY	SCIE	Q2	—	25/82
2002	PHARMACOLOGY & PHARMACY	SCIE	Q1	—	46/188
2001	INFECTIOUS DISEASES	SCIE	Q2	—	11/37
2001	MICROBIOLOGY	SCIE	Q2	—	23/81
2001	PHARMACOLOGY & PHARMACY	SCIE	Q1	—	39/186
2000	INFECTIOUS DISEASES	SCIE	Q1	—	6/36
2000	MICROBIOLOGY	SCIE	Q1	—	15/83
2000	PHARMACOLOGY & PHARMACY	SCIE	Q1	—	24/181
1999	INFECTIOUS DISEASES	SCIE	Q1	—	5/35
1999	MICROBIOLOGY	SCIE	Q1	—	13/79
1998	INFECTIOUS DISEASES	SCIE	Q2	—	11/36
1998	MICROBIOLOGY	SCIE	Q1	—	19/81
1997	INFECTIOUS DISEASES	SCIE	Q2	—	15/34
1997	MICROBIOLOGY	SCIE	Q2	—	23/73